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Background: We previously reported an improvement in early mortality for patients
presenting with acute type A dissection with malperfusion using a strategy of initial
percutaneous intervention to restore end-organ perfusion and delayed operative repair
after resolution of the malperfusion syndrome. This study evaluates the late outcomes
with this approach.
Methods: A total of 196 patients were admitted with acute type A dissection (1997–
2007). Seventy patients with ischemic end-organ dysfunction underwent percutaneous
fenestration or branch vessel stenting. Operative therapy was planned after resolution
of the reperfusion injury. Outcomes were compared for patients with (MP) and without
(UC) dissection with ischemic end-organ dysfunction.
Results: The mean age of the patients was 57.1 years, and 173 patients underwent op-
erative repair (n5 126 UC group; n5 47 MP group). The remaining 23 patients in the
MP group died before repair from complications of malperfusion (11) or aortic rupture
(12) while awaiting resolution of the malperfusion syndrome. Operative mortality was
seen in 9.2% of all patients (9.5% in UC group vs 8.5% in MP group;P5 1.0). On anal-
ysis of the entire cohort (n5 196), the mean survival was higher for the uncomplicated
group (95.9 months for UC group vs 53.7 months for MP group;P, .001). A subgroup
analysis of patients who underwent operation (n5 173) revealed similar mean survival
(95.9 months for UC group vs 80.5 months for MP group; P5 .45).
Conclusion: A strategy of immediate reperfusion, stabilization, and planned operative
repair for acute type A dissection with malperfusion still carries a significant risk for
early and late mortality. However, those patients who survive the initial malperfusion
and undergo repair have a similar operative and late survival when compared with
those patients presenting with uncomplicated dissection.
A
ortic dissection remains the most frequent and lethal complication of thoracic
aortic disease. Although several groups, including the multicenter Interna-
tional Registry of Acute Dissection, have demonstrated improving outcomes
with operative therapy, malperfusion syndrome associated with acute type A dissec-
tion remains a significant adverse risk factor for survival.1-3 Reported in-hospital mor-
tality rates for patients presenting with malperfusion with end-organ dysfunction have
varied from 4% to 90%.4-10
In 1997, we described our early results for a strategy of operative delay for those
patients presenting with acute type A dissection, malperfusion, and ischemic end-
organ dysfunction.4 In that study, a historical cohort of patients presenting with sim-
ilar ischemic end-organ dysfunction from malperfusion taken directly for open repair
were compared with a cohort managed with initial percutaneous fenestration, selec-
tive branch vessel stenting, and delayed operative repair after resolution of the reper-
fusion injury. In contrast with an in-hospital mortality of 89% in the historical group,
those patients who underwent operative delay had an overall 25% mortality, including
a 15% mortality from rupture. These early results led to a consistent strategy at our
institution of restoring end-organ perfusion before operation for all those patients
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CT 5 computed tomography
presenting with acute type A dissection with significant end-
organ ischemia from malperfusion. The current study reports
the long-term results of this approach and describes the out-
comes for the single largest cohort of patients with acute type
A dissection, malperfusion, and ischemic end-organ dysfunc-
tion reported in the literature.
Materials and Methods
This study was approved by the University of Michigan Hospitals
Institutional Review Board (no. 2003–0128). Informed consent
requirements were waived for this study.
We performed a retrospective analysis of data from all patients
who were admitted to the University of Michigan Hospitals with
a diagnosis of acute type A aortic dissection from 1997 to April
of 2007. Acute dissection for this study was defined as its occurrence
within 14 days of presentation to the hospital. A combination of
clinic and hospital records, imaging studies, and query of the Na-
tional Death Index was used to obtain long-term information. A total
of 196 consecutive patients who were evaluated for operative repair
constituted the study cohort. Diagnosis of acute type A dissection
was made by the combination of clinical factors, including history
and physical examination, and either the use of dynamic computed
tomography (CT) or transesophageal echocardiography.
Acute type A dissection without severe ischemic end-organ dys-
function (UC) was suspected in 126 patients, and they proceeded di-
rectly to operative repair. This group included patients without
evidence of angiographic or clinical malperfusion, and patients
who had angiographic malperfusion but did not display evidence
of ischemic end-organ dysfunction (eg, absent femoral pulses but
adequate sensation and motor function of legs, elevated creatinine
with adequate perfusion on CT scan, or compromised true lumen
on CT scan without clinical evidence of ischemia). In these patients,
the standard operative procedure consisted of a median sternotomy
with the rapid institution of cardiopulmonary bypass. An alpha-stat
pH strategy was used on bypass. The extent of proximal resection
generally included native aortic valve preservation and resuspen-
sion, unless contraindicated by the presence of root aneurysm
($4.5 cm) or leaflet pathology. In patients who had a dissection
present in the arch, resection of the proximal hemiarch under deep
hypothermic circulatory arrest was initially performed as a standard
procedure. Extended arch resection was reserved for those patients
in whom the entry tear was identified within the arch, or if an arch
aneurysm of 4.5 to 5.0 cm or more was identified. With increasing
experience with arch resection during the course of the study period,
extended arch repair was also preferentially performed in younger
patients (,65 years) or patients with connective tissue disease in
the presence of dissected aorta alone. The ascending aorta was re-
sected in all patients. Deep hypothermic circulatory arrest was
used as a surgical adjunct in all patients in whom the dissection ex-
tended into the distal ascending aorta or beyond. Neuroprotective
adjuncts during circulatory arrest consisted of retrograde cerebral
perfusion only or a combination of antegrade and retrograde cere-The Journal of Thorabral perfusion depending on the operating surgeon preference. How-
ever, in all cases of extended arch resection, antegrade cerebral
perfusion was used to prevent prolonged cerebral ischemic times.
In addition, the head was packed in ice in all patients during the pe-
riod of cerebral ischemia to prevent rewarming during longer pe-
riods of circulatory arrest. In these situations, cerebral ischemic
times were calculated as the period of time that the patient did not
receive antegrade cerebral flow (ie, either straight hypothermic cir-
culatory arrest or hypothermic circulatory arrest with retrograde ce-
rebral perfusion time). Additional pharmacologic adjuncts included
use of intravenous thiopental (1 g), methylprednisolone sodium suc-
cinate (Solu-Medrol; Pfizer Inc, New York, NY) (1 g), and mannitol
(25 g) administered during the cooling phase when the bladder tem-
perature reached 19C.
On admission to the hospital, 70 patients (35.7%) had suspected
neurologic (stroke or spinal cord ischemia), visceral (abdominal
pain or tenderness, acidosis, hyperamylasemia, elevated transami-
nases, or diarrhea), renal (elevated creatinine and CT evidence of
malperfusion), or limb (absent pulses with limb compromise) mal-
perfusion with end-organ dysfunction (MP). This group underwent
immediate angiography with percutaneous fenestration and aortic
true lumen stenting with or without branch vessel stenting where ap-
propriate. Operative therapy was then planned after resolution of
malperfusion and its associated reperfusion syndrome. It is impor-
tant to note that the decision to delay operative therapy for acute
type A dissection for the reasons of malperfusion was only made af-
ter full evaluation of the entire clinical picture, incorporating infor-
mation from the patient’s history, physical examination results, and
laboratory and imaging data. The mere presence of imaging data
suggesting branch vessel compromise in the absence of either symp-
tomatic or physical findings and abnormal laboratory evaluation re-
sults did not lead to a delay in operation. The details of the initial
clinical scenario prompting delay in aortic repair are listed in Table
1. Presentation in cardiogenic shock was also an indication to pro-
ceed directly for operative repair of the type A dissection, regardless
of the presence of potential branch vessel compromise. The subse-
quent intraoperative strategy for the entire group of patients who un-
derwent a delay strategy, including the need for root or extended
arch aorta resection or use of deep hypothermic arrest, was similar
to that used in the UC group. An outcomes analysis on an intent-
to-treat basis was performed, comparing patients presenting with
uncomplicated (UC, n 5 126) versus suspected malperfusion
(MP, n 5 70) acute dissection. Follow-up was 100% complete at
a mean of 39 6 39 months.
Statistical Analysis
Early outcomes included 30-day or in-hospital rates of mortality,
stroke, renal failure needing dialysis, and the need for tracheostomy.
The primary late outcome of interest was survival time and vital sta-
tus. Early mortality was defined as that occurring within 30 days of
admission or in-hospital death. Late mortality was defined as that oc-
curring thereafter.
Data were analyzed using the Statistical Package for the Social
Sciences (SPSS Inc, Chicago, Ill). All data are expressed as mean
6 standard deviation where applicable. Dichotomous variables
were evaluated using chi-square analysis; continuous variables
were evaluated using analysis of variance (1-way analysis of vari-
ance). Multivariate models (logistic regression for dichotomous var-
iables) were constructed using a backward conditional process tocic and Cardiovascular Surgery c Volume 135, Number 6 1289
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outcomes of interest. The factors used in multivariate analysis for
both the entire cohort and the operated subgroup included using
those with P# .1 significance on univariate analysis. Survival anal-
ysis was analyzed by Kaplan–Meier methods.
Results
The mean age of the study cohort was 57.1 6 14.2 years
(72.4% were male). The comorbidities are listed in Table 2
and were similar between groups. Nine patients (5.2%) pre-
sented in cardiogenic shock from tamponade, and 22 patients
TABLE 1. Initial indications for operative delay strategya
Clinical and radiographic criteria No. affected
Neurologic malperfusion (stroke) 7
Mesenteric malperfusion (all had evidence of
visceral vessel involvement on CT scan)
Acute abdomen 11
Hematochezia or hematemesis 5
Elevated transaminases, amylase, or lipase 3
Severe abdominal pain, nausea, or vomiting 21
Renal malperfusion
Elevated creatinine and renal ischemia/
infarction on CT scan
25
Documented oliguria/anuria and renal
ischemia/infarction on CT scan
5
Limb malperfusion
Loss of pulses with sensorimotor changes 23
CT, Computed tomography. aMore than 1 indication may be present per pa-
tient. If evidence of multiple malperfused beds were present, only those
data prompting angiography were included in this table (eg, in a patient
with an acute abdomen and diminished limb pulses without sensorimotor
changes, malperfusion of the mesenteric bed was identified as the reason
to proceed with interventional study).1290 The Journal of Thoracic and Cardiovascular Surgery c J(11.2%) had previous cardiac surgery. Of the 70 patients pre-
senting with suspected malperfusion and undergoing an
initial percutaneous approach, 23 died before attempted
operative repair. While awaiting resolution of the malperfu-
sion syndrome, 12 of these patients had sudden hemody-
namic collapse and death, consistent with aortic false
lumen rupture. The remaining 11 patients died before opera-
tion from complications from malperfusion syndrome (mul-
tisystem organ failure [n 5 5] and dense neurologic deficit
without recovery [n5 6]). The remaining 47 patients under-
went operative repair.
The overall early mortality rate was lower for the uncom-
plicated subgroup (UC n 5 12 UC [9.5%] vs MP n 5 27
[38.6%]; P , .0001). For univariate and multivariate analy-
ses, an early composite end point of stroke, renal failure need-
ing dialysis, need for tracheostomy, or early mortality was
generated. By univariate analysis, the composite end point
was significantly associated with a history of renal failure
(P 5 .023) or presentation with cardiogenic shock (P 5
.009) or peripheral malperfusion (P, .0001). The only vari-
ables on multivariate analysis that correlated independently
with the composite end point were the history of renal failure
(P 5 .014) or cardiogenic shock (P 5 .008).
The overall late mortality rate was also significantly lower
for the uncomplicated group (UC n5 31 [24.6%] vs MP n5
36 [51.4%]; P, .0001). By univariate analysis, vital status at
last follow-up correlated with age (P 5 .01), preoperative
ejection fraction (P 5 .004), a history of stroke (P 5 .004),
presentation in cardiogenic shock (P 5 .009), or suspected
peripheral malperfusion syndrome (P , .0001). However,
on multivariate analysis, only age (P 5 .009), preoperative
ejection fraction (P 5 .041), or presentation in cardiogenic
shock (P 5 .023) were independently associated with long-
term mortality. Although there was no independent effectTABLE 2. Demographics and univariate analysis of the entire study cohort
Uncomplicated
dissection (n 5 126)
Dissection with ischemic
end-organ dysfunction (n 5 70) P value
Demographics
Age (y) 57.1 6 15.5 57.3 6 11.7 .92
Male sex 91 (72.2%) 51 (72.8%) 1.0
Comorbidities
Previous MI 8 (6.3%) 7 (10%) .39
Previous cardiac surgery 9 (7.1%) 13 (18.6%) .02
Preoperative EF (%) 50.7 6 11.7 49.7 6 9.6 .61
History of tobacco abuse 70 (55.6%) 34 (48.5%) .87
COPD 11 (8.7%) 4 (5.7%) .58
Diabetes 5 (3.9%) 4 (5.7%) .27
Hypertension 91 (72.2%) 46 (65.7%) .87
Preoperative creatinine (mg/dL) 1.23 6 1.57 1.51 6 0.72 .19
Marfan's syndrome 6 (4.8%) 2 (2.9%) .71
PVOD 11 (8.7%) 10 (14.3%) .24
MI, Myocardial infarction; COPD, chronic obstructive pulmonary disease; PVOD, peripheral vascular occlusive disease; EF, ejection fraction.une 2008
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term mortality rate, a survival curve analysis demonstrated
important time-dependent effects of malperfusion syndrome.
This survival analysis is displayed in Figure 1 and demon-
strates a significant decrease in survival for the suspected
malperfusion group (P , .0001). As is evident from the
curves, the predominant difference in mortality is in the early
time period (,3 months). The curves remain relatively paral-
lel thereafter.
Time (months)
144120967248240
C
u
m
u
l
a
t
i
v
e
 
S
u
r
v
i
v
a
l
1.0
0.8
0.6
0.4
0.2
0.0
Entire Cohort Survival Distribution Function
Uncomplicated Dissection
Dissection With Malperfusion
P<0.0001
Figure 1. Entire cohort survival distribution function. This graph
demonstrates that presentation with acute dissection with mal-
perfusion and ischemic end-organ dysfunction is an important ad-
verse risk factor for long-term survival. Mean survival times were
higher in the uncomplicated group (UC 95.9 months vs MP 53.7
months; P< .001). Note that these curves are relatively parallel be-
yond the first 3 months, thus emphasizing the predominant early
effects on survival in patients with malperfusion.The Journal of ThorEffects of Malperfusion of Different Vascular Beds on
Mortality
An analysis was conducted to determine the importance of
malperfusion of different vascular beds on both early and
late mortality. This is detailed in Table 3. Of the 70 patients
diagnosed with end-organ ischemia, 9 did not have angio-
graphic evidence of peripheral vascular compromise at the
time of the study. All patients but one had findings consistent
with mesenteric ischemia on clinical examination (ie, severe
abdominal pain or tenderness, elevated liver or pancreatic en-
zymes, diarrhea, or lactic acidosis.). These patients likely un-
derwent spontaneous reentry between the time of injury and
angiography. On resolution of the reperfusion injury, 8 pa-
tients underwent operative repair a median of 2 days after
the interventional study. This shorter time span compared
with those undergoing fenestration and stenting likely corre-
sponds to the degree and duration of end-organ ischemia and
its associated resolution of reperfusion injury. The remaining
patient found to have fibromuscular dysplasia of the hepatic
and renal arteries on angiography had recently been diag-
nosed with multiple myeloma and had sustained a dense
stroke. On request of the family, care was withdrawn.
Notably, although 26 patients were initially thought to
have end-organ ischemia of multiple vascular beds on clin-
ical grounds, 40 (57.1%) were found to have angiographic
evidence of malperfusion of multiple vascular beds. As is
seen in Table 3, all types of malperfusion correlated with
early mortality on univariate analysis. However, the prog-
nostic independent importance of mesenteric malperfusion
should be noted, because this was the only vascular bed
significantly associated with both early (P 5 .01) and late
mortality (P 5 .04).
Operated Subgroup Analysis
A separate analysis was conducted comparing outcomes for all
those who underwent operative repair. This cohort consisted of
the 126 patients undergoing immediate repair, as well as the 47
(of 70 total) patients presenting with suspected malperfusionTABLE 3. Details regarding malperfusion syndromes
Affected vascular bed No. of patients affected Mortality in affected Mortality in unaffected Univariate P value
Early mortality
Renal 40 14 (35%) 25 (16%) .01
Mesenteric 37 15 (40.5%) 24 (15.1%) .001
Limb 41 14 (34.1%) 25 (16.1%) .01
Neurologic 7 4 (57.1%) 35 (18.5%) .03
Multiple 40 13 (32.5%) 26 (16.7%) .04
Late mortality
Renal 40 17 (42.5%) 50 (32.1%) .26
Mesenteric 37 19 (51.4%) 48 (30.4%) .02
Limb 41 19 (46.3%) 48 (31%) .095
Neurologic 7 5 (71.4%) 62 (32.8%) .047
Multiple 40 17 (42.5%) 50 (32.1%) .26acic and Cardiovascular Surgery c Volume 135, Number 6 1291
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Uncomplicated
dissection (n 5 126)
Dissection with ischemic
end-organ dysfunction (n 5 47) P value
Demographics
Age (y) 57.1 6 15.5 57.9 6 11.1 .76
Male sex 91 (72.2%) 34 (72.3%) 1.0
Comorbidities
Previous MI 8 (6.3%) 5 (10.6%) .33
Previous cardiac surgery 9 (7.1%) 9 (19.1%) .05
Preoperative EF (%) 50.7 6 11.7 49.7 6 9.6 .66
History of tobacco abuse 70 (55.6%) 28 (59.6%) .73
COPD 11 (8.7%) 3 (6.4%) .76
Diabetes 5 (3.9%) 4 (8.5%) .26
Hypertension 91 (72.2%) 37 (78.7%) .44
Preoperative creatinine (mg/dL) 1.23 6 1.57 1.42 6 0.72 .42
Marfan's syndrome 6 (4.8%) 2 (4.3%) 1.0
PVOD 11 (8.7%) 10 (14.3%) .04
Procedural details
Aortic valve resuspension 64 (66.7%) 25 (53.2%) .86
Aortic root replacement 51 (40.4%) 17 (36.1%) .73
Proximal hemiarch replacement 77 (61.1%) 24 (51.1%) .3
Extended arch replacement 44 (34.9%) 23 (48.9%) .12
CABG 11 (8.7%) 2 (4.3%) .52
Need for hypothermic circulatory arrest 117 (92.8%) 45 (95.7%) .73
Use of antegrade cerebral perfusion 55 (43.7%) 26 (55.3%) .22
Cardiopulmonary bypass time (min) 236.6 6 76 246.4 6 93.4 .48
Aortic crossclamp time (min) 176 6 64.6 181.7 6 64.3 .61
Cerebral ischemic time (min) 24.7 6 21 23.1 6 19.9 .7
Lower body hypothermic circulatory arrest time (min) 41.2 6 17.4 46.3 6 19.1 .11
Postoperative morbidity
Operative mortality 12 (9.5%) 4 (8.5%) 1.0
Reoperation for bleeding 14 (11.1%) 4 (8.5%) .78
Deep sternal infection 10 (7.9%) 0 (0%) .06
Stroke 10 (7.9%) 2 (4.3%) .52
Need for dialysis 11 (8.7%) 9 (19.1%) .07
Pneumonia 26 (20.6%) 9 (19.1%) 1.0
Need for tracheostomy 9 (7.1%) 2 (4.3%) .73
Composite outcome 30 (23.8%) 14 (29.8%) .44
Total length of stay (d) 16.8 6 14.6 31.6 6 41.2 .001
MI, Myocardial infarction; COPD, chronic obstructive pulmonary disease; PVOD, peripheral vascular occlusive disease; EF, ejection fraction.who survived to operation. Operative therapy was delayed by
a median of 4 days for the operated MP subgroup. The preop-
erative comorbidities, procedural details, and postoperative
complications are listed in Table 4. Of note, 4 patients were
thought to have renal malperfusion postoperatively and under-
went intervention. Of this group, 3 patients required dialysis,
and 1 patient (with a prolonged postoperative course) died of
upper gastrointestinal hemorrhage.
Univariate analysis of the occurrence of the early compos-
ite outcome is listed in Table 5. Multivariate logistic regres-
sion, including those variables from Table 5, demonstrated
that only preoperative creatinine (P 5 .02), presentation in
cardiogenic shock (P 5 .02), and duration of cardiopulmo-1292 The Journal of Thoracic and Cardiovascular Surgery c Jnary bypass (P 5 .002) correlated independently with the
composite outcome.
Finally, long-term mortality was seen in 44 (25.4%) of the
173 patients undergoing operative repair (UC n 5 31
[24.6%] vs operated MP n5 13 [27.6%]; P5 .7). Univariate
analysis of factors used in multivariate analysis for long-term
mortality is shown in Table 5. Logistic regression demon-
strated that only duration of cerebral ischemic time (P 5
.005) correlated independently with long-term mortality. In
this analysis, suspected preoperative malperfusion was not
correlated with a higher long-term mortality rate (UC
24.6% vs MP 27.6%), P 5 .7) and did not affect survival
times (P 5 .45; Figure 2).une 2008
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Mortality in acute type A dissection results not only from the
rupture of a dissected ascending aorta but also from the asso-
ciated ischemic end-organ dysfunction from malperfusion.
Our group and others have described the pathophysiology
of peripheral malperfusion secondary to aortic dissection.4,5
This work suggests that end-organ ischemia can result from
a static obstruction (flap enters and narrows branch vessel lu-
men), dynamic obstruction (flap covers orifice of branch ves-
sel), or a combination of these 2 mechanisms. As we and
others have demonstrated, either mechanism is amenable to
percutaneous therapy, with subsequent rapid restoration of
end-organ perfusion.4,10
Traditional therapy for acute type A dissection entails im-
mediate operative repair to prevent rupture and death. Cam-
bria and colleagues5 and Lauterbach and colleagues6 called
to attention the high rates of morbidity and mortality associ-
ated with malperfusion syndrome, particularly for the sub-
groups with renal or mesenteric malperfusion. They
suggested that the optimal approach in that setting consisted
of initial operative revascularization with subsequent central
aortic repair. In contrast, Fann and colleagues7 have sug-
gested that immediate aortic repair with proximal false lumen
obliteration and reestablishment of true lumen flow may
restore peripheral arterial perfusion without the need for asso-
ciated peripheral arterial revascularization. This group also
TABLE 5. Univariate analysis for group undergoing
operative repair
Variable P value
Early composite outcome
Age .073
Preoperative creatinine .004
PVOD .06
Cardiogenic shock .009
Need for CABG .02
Need for hypothermic circulatory arrest .066
Cardiopulmonary bypass time ,.0001
Aortic crossclamp time .015
Lower body circulatory arrest time .001
Late mortality
Age .001
Ejection fraction .002
Cardiogenic shock .009
Presentation with renal malperfusion .06
Cardiopulmonary bypass time .001
Aortic crossclamp time .046
Lower body circulatory arrest time .002
Cerebral ischemic time ,.0001
Need for CABG .097
Use of antegrade cerebral perfusion .078
Postoperative stroke .078
PVOD, Peripheral vascular occlusive disease; CABG, coronary artery by-
pass grafting.The Journal of Thornoted the incidence of mortality to be significantly elevated
(.50%) in those subgroups with renal and mesenteric ische-
mia. Others have also suggested similar outcomes with pref-
erential aortic repair.8
In our first study in 1997, we described a comparative
analysis of patients treated with immediate operation regard-
less of peripheral vascular involvement and patients treated
with a selective operative delay.4 That study suggested that
there was a significantly higher risk of mortality (89% vs de-
lay 25%, P 5 .003) with immediate central aortic repair in
those patients with malperfusion syndrome and ischemic
end-organ dysfunction. On the basis of this previous work,
our algorithm during the last decade for managing patients
with acute type A dissection is to proceed with immediate op-
erative repair unless there is evidence of ischemic end-organ
dysfunction and malperfusion. This group includes those
with 1) no CT angiographic evidence of malperfusion; 2)
CT angiographic malperfusion without severe end-organ
dysfunction; 3) absent peripheral pulses with intact sensation
and motor function of the affected limb; 4) evidence of ele-
vated creatinine without CT evidence of malperfusion; and
5) evidence of a compromised true lumen and no clinical ev-
idence of end-organ ischemia and dysfunction. In contrast,
those patients who presented with evidence of neurologic,
visceral, renal, or limb malperfusion with end-organ damage
proceeded directly for percutaneous intervention with aortic
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Figure 2. Survival distribution function for operated subgroup. For
those patients surviving to operative repair, survival is similar for
both patients initially presenting with uncomplicated acute dis-
section and those initially presenting with malperfusion and
end-organ ischemia syndrome (UC 95.9 months vs MP 80.5 months;
P 5 .45).acic and Cardiovascular Surgery c Volume 135, Number 6 1293
Surgery for Acquired Cardiovascular Disease Patel et al
A
CDfenestration, true lumen, or branch vessel stenting where ap-
propriate. The purpose of this report was not to ascertain the
more suitable strategy for patients presenting with malperfu-
sion (ie, immediate repair for all vs selective operative delay).
We believe that early operative repair is indicated in the ma-
jority of patients to decrease the risk of dissection-related
mortality. Rather, this study was undertaken to describe
long-term results associated with a consistent application of
a selective operative delay approach in those patients present-
ing with significant ischemic end-organ dysfunction as a con-
sequence of prolonged branch vessel compromise. In doing
so, we assessed the outcomes for the largest group of patients
with type A dissection with malperfusion and ischemic end-
organ dysfunction reported in the literature. In addition,
although most previous studies have focused on early com-
plication rates, few have determined the long-term outcomes
for this cohort.11
The long-term results from this study suggest that malper-
fusion syndrome is an important adverse risk factor for long-
term survival. The importance of mesenteric malperfusion
syndrome as an independent adverse risk factor for early
and late mortality has been noted in this study and by
others.4-8 The early mortality rate of 40.5% for patients with
mesenteric malperfusion in our report is consistent with the
contemporary results reported by Lauterbach and colleagues,6
who also espouse operative delay for this subset of patients
with acute type A dissection.
In contrast, the long-term results in our study differ when
the analysis is conducted on those who underwent operative
repair. In this subgroup, the survival curves of patients with
malperfusion who eventually proceeded to operative repair
were restored to the level of those who presented with un-
complicated dissection. Although this is admittedly a highly
selected group, it suggests the effects of malperfusion syn-
drome are primarily seen early. Indeed, in the survival anal-
ysis of the entire cohort, the predominant difference in
survival is seen in the first 3 months with relatively parallel
survival curves thereafter, further supporting the notion of
predominantly early effects of malperfusion.
The recent report by Geirsson and colleagues11 from the
University of Pennsylvania deserves mention. They sug-
gested that although an approach espousing early repair is as-
sociated with a higher in-hospital mortality for the group with
malperfusion (30.5% vs 6.2% in non-malperfusion), long-
term survival may be similar between groups. Although their
data suggest an early mortality similar to that of our strategy
of operative delay for malperfusion (38.7% for all malperfu-
sion in this report), their group had a significantly different
profile than in our study. In particular, although the preva-
lence of both renal and mesenteric malperfusion with end-or-
gan dysfunction was high in our study (57.1% and 52.1%,
respectively), their report had a significantly lower incidence
of malperfusion of these beds (renal 5 4.1%; mesenteric 5
1.4%). Because we and others have suggested a lower sur-1294 The Journal of Thoracic and Cardiovascular Surgery c Jvival for these groups, the results from their study may not
be suitable for comparison with our data.
A final important point should be noted. Because of our
previous work with acute dissection and malperfusion, we
have noted a dramatic increase in referrals of patients present-
ing with this complication. Geographic considerations and
referral patterns often result in patients presenting to other in-
stitutions ($1) before transfer to the University of Michigan.
These transfers increase the time interval between the onset
of dissection with malperfusion to the time of definitive treat-
ment and worsen the degree of ischemic end-organ dysfunc-
tion. These considerations may explain some differences
between other series and ours, and may also account for the
relatively high proportion of patients with malperfusion
seen in our study compared with others.
Limitations of this study include the lack of a comparison
group (ie, a cohort undergoing immediate operation regard-
less of malperfusion status). However, this was not the intent
of our study; rather, the focus was to analyze the long-term
results of an adopted strategy of operative delay for acute dis-
section and ischemic end-organ dysfunction. Operative delay
while awaiting resolution of the malperfusion syndrome in
these patients is associated with a significant risk for early
mortality from either aortic false lumen rupture or complica-
tions of the malperfusion syndrome. A future study could
therefore evaluate whether earlier operative therapy (ie, oper-
ation immediately after fenestration and stenting) could im-
prove results by ameliorating the risk for early rupture and
subsequent mortality. It is possible that the beneficial effects
of avoidance of rupture may be offset by a higher operative
mortality in the setting of significant ischemia-reperfusion in-
jury and its deleterious consequences.4
Conclusions
Presentation with acute dissection, malperfusion, and ische-
mic end-organ dysfunction is an important adverse risk factor
for survival, particularly in the setting of mesenteric ische-
mia. A strategy of immediate percutaneous reperfusion and
delayed operative repair to allow resolution of malperfusion
and associated reperfusion injury still carries a significant risk
for early mortality. However, in those patients who undergo
operative repair with this approach, survival times are re-
stored to those who present without evidence of ischemic
end-organ dysfunction.
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Discussion
Dr Roderick Macarthur (Edmonton, Alberta). I thank the associ-
ation for the opportunity to discuss this article, and congratulations
to Dr Patel and colleagues for an excellent and provocative article
addressing the management of patients with acute type A aortic dis-
section presenting with severe coexisting malperfusion. We are re-
minded by this article of the challenges in dealing with this high-
risk group of patients. The Michigan group’s approach to this cohort
of patients has been consistent with primary percutaneous fenestra-
tion followed by delayed central aortic repair once patients have sta-
bilized and their end-organ ischemic injury has resolved. This
strategy originated from a poor outcome with primary central aortic
repair in this group of patients.
I think this is an important article in that it provides follow-up to
a controversial article the authors published almost a decade ago.
The authors should be commended for providing an updated report
regarding the outcomes associated with their approach to these pa-
tients. Many times, controversial approaches are introduced in the
literature but never followed up with the appropriate studies. This
makes it difficult to know which approach has been proven effica-
cious in the long run and which has not. The authors are also clear
that the purpose of the article is not to compare immediate central
repair with delayed surgery but to evaluate the long-term outcomes
when their delayed approach is used. The delayed approach has sig-
nificantly improved the outcomes in their institution for this high-
risk group of patients, and they should be congratulated.
I do believe, however, that this article challenges what many of
us currently teach our trainees, that many of these malperfusion syn-
dromes will resolve with primary central aortic repair and acute type
A aortic dissection is a surgical emergency that requires immediate
surgical repair.
I have 4 questions for Dr Patel. Clearly it is in the group of pa-
tients with severe malperfusion that this strategy is used in your in-
stitution. How do you define severe malperfusion? For example, areThe Journal of Thorapatients with paraplegia delayed for surgical repair? How do you de-
fine renal malperfusion? What are the determinants that indicate that
it is now appropriate to proceed with surgical repair and that the pa-
tient has been sufficiently delayed?
Dr Patel. Typically when a patient presents at the University of
Michigan with acute type A aortic dissection, our algorithm in-
volves precisely what I mentioned. Those patients who present
with tamponade or coronary malperfusion without evidence of
a dead ventricle (eg, regardless of malperfusion) will proceed di-
rectly to operation. If patients present with severe malperfusion
with end-organ dysfunction, for example, those with significantly
abnormal or increasing creatinine, severe abdominal pain, abnormal
abdominal exam, or neurologic malperfusion with dense stroke or
paraplegia, their operative procedure will be delayed until their
ischemia reperfusion injury resolves. This would be evident by de-
creasing creatinine, restoration of urine output, or benign abdominal
exam. It is important to note that a specific objective number is not
targeted for us to decide on the date of operation, but rather the entire
clinical picture is used to determine the optimal time of aortic repair.
Dr Macarthur. Many advances in the management of these
complex cases have taken place during the past years. For example,
some believe that antegrade perfusion from the outset with right ax-
illary cannulation is beneficial, particularly in patients with malper-
fusion. Do you believe that strategies and other such advances will
affect the outcome in this high-risk group of patients? Do you antic-
ipate this influencing the management of your delayed strategy?
Dr Patel. I am not sure how axillary perfusion would alter per-
fusion to the end organs because the path of blood flow often will be
similar to that seen with restoring perfusion in an antegrade fashion.
DrMacarthur. How often did the percutaneous interventions in
the malperfusion group successfully reestablish flow within a com-
promised branch vessel, and were there any direct complications
from this procedure, for example, in the 23 patients who died while
awaiting surgical repair, were any of those deaths due to complica-
tions from the fenestration procedure?
Dr Patel. We are very fortunate. We have a good interventional
radiology team that we work closely with, and thankfully none of the
complications, none of the mortality that was seen in those patients
who were awaiting resolution of the malperfusion syndrome, were
attributed directly to the results of the fenestration procedure.
Dr Macarthur. My final question is, have the authors consid-
ered the thoracoabdominal aorta in this group of patients and does
a delayed approach influence a requirement for the risk and need
for subsequent distal surgery? What is your follow-up imaging strat-
egy in these patients and does it differ from patients presenting with-
out malperfusion?
Dr Patel. Typically the thoracoabdominal aorta is dissected in
these patients who present with malperfusion. Our approach of cre-
ating a flap fenestration may prevent total thrombosis of the residual
dissected aorta by creating a large reentry tear, but that is uncertain
and is a subject of future study. Our followup in all patients following
repair of acute Type A dissection, whether malperfusion existed or
not is the same. We image them with echocardiography and CT scan-
ning only (3 and 9 months) and then annually thereafter if the aorta
remains stable. Our indications for intervening on the distal dissected
aorta are the standard ones, namely size, growth or symptoms.
Dr Craig Miller (Stanford, Calif). Thank you for updating the
Michigan series. I will never forget in January 1996 when Mikecic and Cardiovascular Surgery c Volume 135, Number 6 1295
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took a lot of flack.
Dr Patel. He still has some bullet holes I think. [laughter]
DrMiller. It is good to see the follow-up. I am not sure, however,
exactly what you have learned from the last 10 years; perhaps the
most salient question I need to ask is how many patients did you ac-
tively decide to do nothing for because of irreversible infarction of the
gut, kidney, brain, or some other important end organ? Are you still in
the ‘‘warm autopsy’’ mode that Mike was accused of 11 years ago?
Dr Patel.Of the 23 patients who died, 11 expired directly as a re-
sult of malperfusion syndrome with multisystem organ failure. Half
of these had dense neurologic deficits and never recovered. The re-
maining 12 patients ruptured while awaiting resolution of their mal-
perfusion syndrome. In this group, evidence of severe ischemia
reperfusion injury was still apparent, and included for example, pa-
tients who required laparotomy for bowel resection.
Dr Chad Hughes (Durham, NC). I have a couple questions for
you. Maybe I just missed it, but did you break down the difference—
I mean, I think dynamic malperfusion of the gut and static malper-
fusion of the gut are 2 different animals. If someone presents acutely
with acute type A dissection, with some abdominal pain and evi-
dence of dynamic malperfusion on CT scan, that should get better
by replacing the ascending aorta, but if it is static malperfusion
and the superior mesenteric artery is thrombosed, that is obviously
not going to get better by reestablishing true lumen flow. In our ex-
perience, that has a much higher mortality rate, and those are the pa-
tients in whom we will typically place branched vessel grafts into the
superior mesenteric artery or celiac first before we do the ascending
aorta, versus if it is just dynamic malperfusion, we would expect that
to get better by replacing the ascending aorta. Have you looked at the
difference between those?
Dr Patel. We have not. It is an interesting point, but the intention
of this analysis was to look at the outcomes on an intent-to-treat basis.
You cannot always sort out the dynamic vs. static mechanism on the
preoperative CT scan. We agree that dynamic obstruction will re-
solve with central aortic repair. However, in the group treated with1296 The Journal of Thoracic and Cardiovascular Surgery c Junoperative delay in this presentation were those that had evidence of
significant end-organ ischemia with dysfunction. I think that was
the biggest point that Mike had tried to make in the original presen-
tation, namely that a difference exists between end-organ ischemia
and end-organ ischemia with severe end-organ dysfunction. It was
the our intent to focus on that latter group in both the first and the
current study.
Dr Hughes. I think it depends on how early they present. My
second question is on fenestrations. Have you tried, which we
have done, just using endografts instead only in the true lumen?
We have had, at least in our institution, better success with that com-
pared with fenestration, especially for dynamic malperfusion, to
open the true lumen.
In your delayed group, are any of the deaths due to rupture of the
aorta or severe aortic insufficiency with heart failure rather than mal-
perfusion syndrome?
Dr Patel. I am not sure that treating a dissected thoracobdominal
aorta with a thoracic endograft is the best therapy. I think that one of
the biggest issues is that in this situation, both the proximal and dis-
tal landing zones are not necessarily stable since the aorta is not nor-
mal. Secondly, you would be covering up multiple intercostals, and
thus subjecting patients to a risk for paralysis. When we perform per-
cutaneous fenestration and stenting, it is a percutaneous procedure
maintaining intercostal artery patency and avoiding the need to de-
liver larger bore devices through a femoral cutdown.
Regarding the second question concerning cardiac causes of
death, it is important to note that in contrast to the original study
where there were patients with severe ventricular dysfunction and
coronary malperfusion, for some reason in this study no patients
with this scenario were seen during the current study period. If pa-
tients had severe aortic insufficiency and had severe ischemic end-
organ dysfunction, operative delay was utilized in some. However,
if they did not appear to be tolerating the AI, we proceeded to oper-
ative repair earlier. Again, what is important to note is that the clin-
ical decision to proceed with surgery was undertaken after
evaluating the entire clinical scenario.e 2008
